Nanjing Vishee Medical Technology Co., Ltd (688580.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap4.85B
EV4.85B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
14.0
21.0
30.3
46.4
55.1
62.6
46.8
—
Revenue % Chg.
—
50.7%
43.8%
53.5%
18.7%
13.7%
-25.2%
—
Cost of Revenue
3.7
5.5
7.8
12.2
14.5
15.8
12.9
—
Gross Profit
10.2
15.5
22.4
34.2
40.6
46.8
34.0
—
Gross Profit Margin
73.4%
73.8%
74.2%
73.7%
73.6%
74.8%
72.5%
—
R&D Expenses
1.3
1.9
2.7
4.0
5.0
9.3
6.4
—
Selling, General, & Admin Expenses
6.1
7.1
9.1
12.3
12.4
13.4
14.7
—
Other Expenses
0.2
-0.1
0.5
1.7
1.9
1.1
2.6
—
Operating Income
2.7
6.8
10.5
16.7
24.0
28.4
15.2
—
Operating Income Margin
19.1%
32.4%
34.7%
36.0%
43.6%
45.3%
32.5%
—
Total Other Income/Expenses Net
1.3
-0.0
0.2
0.0
0.2
0.4
0.2
—
Income Before Tax
3.9
6.8
10.7
16.7
24.2
28.7
15.4
—
Income Before Tax Margin
28.1%
32.3%
35.3%
36.0%
43.9%
45.9%
32.9%
—
Income Tax Expense
0.6
1.0
1.5
2.3
3.3
2.9
1.7
—
Net Income
3.4
5.9
9.2
14.5
20.9
25.9
13.7
—
Net Income Margin
24.1%
27.9%
30.5%
31.3%
38.0%
41.3%
29.2%
—
Weighted Avg. Shares Out
50.0
50.7
51.3
51.3
58.4
68.3
68.3
—
EPS
0.1
0.1
0.2
0.3
0.4
0.4
0.2
—
EPS % Chg.
—
72.8%
55.0%
57.3%
26.2%
5.7%
-47.3%
—
Weighted Avg. Shares Out Dil
—
—
—
—
58.4
68.5
68.3
—
EPS Diluted
0.1
0.1
0.2
0.3
0.4
0.4
0.2
—
Interest Income
0.0
0.0
0.0
0.0
0.9
2.4
2.8
—
Interest Expense
-0.0
-0.0
0.1
0.1
0.1
0.0
0.0
—
EBIT
4.0
6.9
10.6
16.6
25.1
31.2
18.2
—
EBIT Margin
28.3%
32.6%
35.1%
35.8%
45.5%
49.8%
38.8%
—
Depreciation & Amortization
0.1
0.0
0.9
1.3
1.6
2.2
2.8
—
EBITDA
4.1
6.9
11.5
17.9
26.7
33.3
21.0
—
EBITDA Margin
29.1%
32.7%
37.9%
38.6%
48.4%
53.2%
44.9%
—